Skip to main content
. 2021 Oct 30;20:217. doi: 10.1186/s12933-021-01405-4

Table 1.

Baseline patient, lesion and procedural characteristics

Baseline characteristics, No. (%)
Normoglycemia
n = 2353
Prediabetes
n = 489
Diabetes
n = 1488
P-value
Age, mean (SD), years 62.9 (10.8) 64.6 (10.8) 65.7 (10.6) < 0.001
Female 568 (24.1) 142 (29.0) 439 (29.5) < 0.001
Body mass index, mean (SD), kg/m2 26.9 (3.8) 27.9 (4.3) 29.1 (4.7) < 0.001
Hypertension 933 (39.7) 236/488 (48.4) 948/1484 (63.9) < 0.001
Hypercholesterolemia 909/2351 (38.7) 204/488 (41.8) 746/1479 (50.4) < 0.001
Current smoker 764/2299 (33.2) 140/467 (30.0) 376/1440 (26.1) < 0.001
Renal insufficiencya 55 (2.3) 21 (4.3) 114 (7.7) < 0.001
Previous stroke 137 (5.8) 35 (7.2) 137 (9.2) < 0.001
Previous myocardial infarction 350 (14.9) 91 (18.6) 320 (21.5) < 0.001
Previous PCI 359 (15.3) 100 (20.4) 368 (24.7) < 0.001
Previous CABG 140 (5.9) 40 (8.2) 156 (10.5) < 0.001
Clinical presentation 0.001
 STEMI 763 (32.4) 146 (29.9) 379 (25.5)
 Non-STEMI 521 (22.1) 98 (20.0) 345 (23.2)
 Unstable angina 389 (16.5) 94 (19.2) 278 (18.7)
 Stable angina 680 (28.9) 151 (30.9) 486 (32.7)
Lesion and procedural characteristics
 At least 1 severely calcified lesion 450 (19.1) 108 (22.1) 344 (23.1) 0.009
 At least 1 bifurcation treated 828 (35.2) 183 (37.4) 551 (37.0) 0.41
 Graft treated 32 (1.4) 12 (2.5) 37 (2.5) 0.026
 Small vessel treated (< 2.75mm) 1256 (53.4) 282 (57.7) 910 (61.2) < 0.001
 Multivessel treatment 398 (16.9) 100 (20.4) 275 (18.5) 0.13
 Total stent length/patient, median (IQR) 32 (20–52) 31 (20–53) 30 (18–48) 0.86
 Direct stenting 265 (15.6) 53 (14.1) 147 (16.1) 0.67
 Postdilation 1913 (81.3) 399 (81.6) 1,121(75.3) < 0.001
 Number of diseased vessels > 50 % angiographic stenosis < 0.001
  One vessel disease 1380 (58.6) 274 (56.0) 757 (50.9)
  Two vessel disease 737 (31.3) 158 (32.3) 487 (32.7)
  Three vessel disease 236 (10.0) 57 (11.7) 244 (16.4)

Values are n/N (%), mean (SD), or median (IQR)

CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention; STEMI, ST-segment-elevation myocardial infarction; NSTEMI, non-ST-segment-elevation myocardial infarction

aDefined as creatinine level ≥ 130 µmol/l, an estimated glomerular filtration rate of less than 30 ml per minute per 1.73 m2 of body-surface area, or the need for dialysis